Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Gabriel C Quintero Garzola. (2020) The Use of Gabapentin for the Treatment of Alcohol and Tobacco Use Disorders: A Review. Open Access Journal of Clinical Trials 12, pages 43-60.
Read now
Read now
Kenneth A Perkins. (2014) Improving efficiency of initial tests for efficacy in smoking cessation drug discovery. Expert Opinion on Drug Discovery 9:11, pages 1259-1264.
Read now
Read now
Manfred A. Lutz, Pedro Lovato & Genaro Cuesta. (2012) Cost Analysis of Varenicline Versus Bupropion, Nicotine Replacement Therapy, and Unaided Cessation in Nicaragua. Hospital Practice 40:1, pages 35-43.
Read now
Read now
Manfred A. Lutz, Pedro Lovato & Genaro Cuesta. (2012) Cost-Effectiveness Analysis of Varenicline Versus Existing Smoking Cessation Strategies in Central America and the Caribbean Using the BENESCO Model. Hospital Practice 40:1, pages 24-34.
Read now
Read now
Robert
A. Schnoll, Joseph Cappella, Caryn Lerman, Angela Pinto, Freda Patterson, E. Paul Wileyto, Cabral Bigman & Frank Leone. (2011) A Novel Recruitment Message to Increase Enrollment Into a Smoking Cessation Treatment Program: Preliminary Results From a Randomized Trial. Health Communication 26:8, pages 735-742.
Read now
Read now
Rafael Laniado-Laborín. (2010) Smoking Cessation Intervention: An Evidence-Based Approach. Postgraduate Medicine 122:2, pages 74-82.
Read now
Read now
Riju Ray, Rachel F. Tyndale & Caryn Lerman. (2009) Nicotine Dependence Pharmacogenetics: Role of Genetic Variation in Nicotine-Metabolizing Enzymes. Journal of Neurogenetics 23:3, pages 252-261.
Read now
Read now
IvanD. Montoya & Frank Vocci. (2007) Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia. Journal of Dual Diagnosis 3:3-4, pages 113-150.
Read now
Read now
Aracy PS Balbani & Jair C Montovani. (2007) Recent developments for smoking cessation and treatment of nicotine dependence. Expert Opinion on Therapeutic Patents 17:3, pages 287-297.
Read now
Read now
Articles from other publishers (82)
Sung Hoon Jeong, Doo Woong Lee, Soo Hyun Kang, Seung Hoon Kim, Eun-Cheol Park & Jaeyong Shin. (2022) Association Between Changes in Depressive Symptoms and Hazardous Drinking: Findings From the Korea Welfare Panel Study (2013–2018). Frontiers in Public Health 9.
Crossref
Crossref
Soo Hyun Kang, Wonjeong Jeong, Sung-In Jang & Eun-Cheol Park. (2021) The effect of depression status change on daily cigarette smoking amount according to sex: an eleven-year follow up study of the Korea Welfare Panel Study. BMC Public Health 21:1.
Crossref
Crossref
Immaculate M. Langmia, Katja S. Just, Sabrina Yamoune, Jürgen Brockmöller, Collen Masimirembwa & Julia C. Stingl. (2021) CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations—Implication for Drug Safety, Dosing, and Individualized Therapy. Frontiers in Genetics 12.
Crossref
Crossref
Freda Patterson, Michael A. Grandner, Susan K. Malone, Ryan T. Pohlig, Rebecca L. Ashare & David G. Edwards. (2020) Efficacy of a sleep health intervention to optimize standard smoking cessation treatment response: results from a pilot randomized controlled trial. Journal of Smoking Cessation 15:2, pages 113-117.
Crossref
Crossref
Jeong-Won Han & Hanna Lee. (2020) The effects of hardcore smokers' depression and self-esteem on daily smoking amount. Archives of Psychiatric Nursing 34:3, pages 149-158.
Crossref
Crossref
Roger L. Papke & Jon M. Lindstrom. (2020) Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling. Neuropharmacology 168, pages 108021.
Crossref
Crossref
Luiz H. Araujo, Leora Horn, Robert E. Merritt, Konstantin Shilo, Meng Xu-Welliver & David P. Carbone. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1108
1158.e16
.
Otto-Michael Lesch, Henriette Walter, Samuel Pombo, Victor Hesselbrock & Michie Hesselbrock. 2020. Alkohol und Tabak. Alkohol und Tabak
189
270
.
Otto-Michael Lesch, Henriette Walter, Christian Wetschka, Michie N. Hesselbrock, Victor Hesselbrock & Samuel PomboOtto-Michael Lesch, Henriette Walter, Christian Wetschka, Michie N. Hesselbrock, Victor Hesselbrock & Samuel Pombo. 2020. Alcohol and Tobacco. Alcohol and Tobacco
195
270
.
Freda Patterson, Elizabeth Connick, Benjamin Brewer & Michael A. Grandner. (2019) HIV status and sleep disturbance in college students and relationship with smoking. Sleep Health 5:4, pages 395-400.
Crossref
Crossref
Reagan R. Wetherill, Hengyi Rao, Nathan Hager, Jieqiong Wang, Teresa R. Franklin & Yong Fan. (2018)
Classifying and characterizing nicotine use disorder with high accuracy using machine learning and resting‐state
fMRI
. Addiction Biology 24:4, pages 811-821.
Crossref
Crossref
Freda Patterson & Rebecca Ashare. 2019. Sleep and Health. Sleep and Health
283
301
.
Chandni Hindocha, Tom P. Freeman, Meryem Grabski, Jack B. Stroud, Holly Crudgington, Alan C. Davies, Ravi K. Das, William Lawn, Celia J. A. Morgan & H. Valerie Curran. (2018) Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal. Addiction 113:9, pages 1696-1705.
Crossref
Crossref
Deniz Bagdas, Yasmin Alkhlaif, Asti Jackson, F. Ivy Carroll, Joseph W. Ditre & M. Imad Damaj. (2018) New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice. Neuropharmacology 138, pages 72-79.
Crossref
Crossref
Cheyenne Allenby & Mary Falcone. (2017) Using Genetics to Improve Addiction Treatment Outcomes. Current Behavioral Neuroscience Reports 4:1, pages 1-9.
Crossref
Crossref
B. Joly, P. D’Athis, L. Gerbaud, J. Hazart, J. Perriot & C. Quantin. (2016) Smoking cessation attempts: is it useful to treat hard core smokers?. Tobacco Induced Diseases 14:1.
Crossref
Crossref
Meryem Grabski, H. Valerie Curran, David J. Nutt, Stephen M. Husbands, Tom P. Freeman, Meg Fluharty & Marcus R. Munafò. (2016) Behavioural tasks sensitive to acute abstinence and predictive of smoking cessation success: a systematic review and meta-analysis. Addiction 111:12, pages 2134-2144.
Crossref
Crossref
Staci Robinson Allen & Donna Kritz-Silverstein. (2016) Dental vs. Medical Students’ Comfort with Smoking Cessation Counseling: Implications for Dental Education. Journal of Dental Education 80:8, pages 959-965.
Crossref
Crossref
R L Ashare, B A Kimmey, L E Rupprecht, M E Bowers, M R Hayes & H D Schmidt. (2016) Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers. Translational Psychiatry 6:1, pages e713-e713.
Crossref
Crossref
M.P. Faillace, J. Zwiller & R.O. Bernabeu. (2015) Effects of combined nicotine and fluoxetine treatment on adult hippocampal neurogenesis and conditioned place preference. Neuroscience 300, pages 104-115.
Crossref
Crossref
Kenneth A. Perkins, Joshua L. Karelitz, Valerie C. Michael, Margaret Fromuth, Cynthia A. Conklin, K. N. Roy Chengappa, Chris Hope & Caryn Lerman. (2015) Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence. Nicotine & Tobacco Research, pages ntv085.
Crossref
Crossref
Shafiqur Rahman, Eric A. Engleman & Richard L. Bell. (2015) Nicotinic receptor modulation to treat alcohol and drug dependence. Frontiers in Neuroscience 8.
Crossref
Crossref
Audrey Darville & Ellen J. Hahn. (2014) Hardcore smokers: What do we know?. Addictive Behaviors 39:12, pages 1706-1712.
Crossref
Crossref
Elise M. Weerts, Gary S. Wand, Hiroto Kuwabara, Xiaoqiang Xu, J. James Frost, Dean F. Wong & Mary E. McCaul. (2014) Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects. Addiction Biology 19:4, pages 733-742.
Crossref
Crossref
Blake A. Kimmey, Laura E. Rupprecht, Matthew R. Hayes & Heath D. Schmidt. (2014) Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats. Addiction Biology 19:4, pages 539-551.
Crossref
Crossref
Alison M. Diaper, Fergus D. Law & Jan K. Melichar. (2014) Pharmacological strategies for detoxification. British Journal of Clinical Pharmacology 77:2, pages 302-314.
Crossref
Crossref
Leora Horn, Rosana Eisenberg, David Gius, Katherine N. Kimmelshue, Pierre P. Massion, Joe Bill Putnam, Clifford G. Robinson & David P. Carbone. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1143
1192.e13
.
Kenneth A. Perkins & Caryn Lerman. (2013) An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. Psychopharmacology 231:1, pages 1-11.
Crossref
Crossref
Arpana Agrawal & Michael T. Lynskey. 2014. Behavior Genetics of Psychopathology. Behavior Genetics of Psychopathology
185
230
.
S. Charntikov, N. Swalve, S. Pittenger, K. Fink, S. Schepers, G.C. Hadlock, A.E. Fleckenstein, G. Hu, M. Li & R.A. Bevins. (2013) Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotine. Neuropharmacology 75, pages 138-144.
Crossref
Crossref
Christina E. Ciaccio & Deborah Gentile. (2013) Effects of Tobacco Smoke Exposure in Childhood on Atopic Diseases. Current Allergy and Asthma Reports 13:6, pages 687-692.
Crossref
Crossref
Alexandra Elizabeth ShieldsMehdi Najafzadeh & Anna Boonin Schachter. (2013) Bumps along the translational pathway: anticipating uptake of tailored smoking cessation treatment. Personalized Medicine 10:8, pages 813-825.
Crossref
Crossref
Nobuyuki Hizawa. (2013) Pharmacogenetics of chronic obstructive pulmonary disease. Pharmacogenomics 14:10, pages 1215-1225.
Crossref
Crossref
Rebecca L. Ashare, Riju Ray, Caryn Lerman & Andrew A. Strasser. (2012) Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: A pilot feasibility study. Drug and Alcohol Dependence 126:1-2, pages 263-267.
Crossref
Crossref
Thomas J Hopkins, Laura E Rupprecht, Matthew R Hayes, Julie A Blendy & Heath D Schmidt. (2012) Galantamine, an Acetylcholinesterase Inhibitor and Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors, Attenuates Nicotine Taking and Seeking in Rats. Neuropsychopharmacology 37:10, pages 2310-2321.
Crossref
Crossref
A Agrawal, K J H Verweij, N A Gillespie, A C Heath, C N Lessov-Schlaggar, N G Martin, E C Nelson, W S Slutske, J B Whitfield & M T Lynskey. (2012) The genetics of addiction—a translational perspective. Translational Psychiatry 2:7, pages e140-e140.
Crossref
Crossref
Allison B. Gold & Caryn Lerman. (2012) Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Human Genetics 131:6, pages 857-876.
Crossref
Crossref
Tony P. George. 2012. Goldman's Cecil Medicine. Goldman's Cecil Medicine
142
146
.
Robert A SchnollFrank T Leone. (2011) Biomarkers to optimize the treatment of nicotine dependence. Biomarkers in Medicine 5:6, pages 745-761.
Crossref
Crossref
Derek S. Wilkinson & Thomas J. Gould. (2011) The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice. Behavioural Brain Research 223:1, pages 53-57.
Crossref
Crossref
Jessica E. Sturgess, Tony P. George, James L. Kennedy, Andreas Heinz & Daniel J. Müller. (2011) Pharmacogenetics of alcohol, nicotine and drug addiction treatments. Addiction Biology 16:3, pages 357-376.
Crossref
Crossref
Elyse R. Park, Susan Kleimann, Emily J. Youatt, Abigail Lockhart, Eric G. Campbell, Douglas E. Levy, Chanita Hughes Halbert, Erin Schmieder, Rasika Krishna & Alexandra E. Shields. (2011) Black and White adults' perspectives on the genetics of nicotine addiction susceptibility. Addictive Behaviors 36:7, pages 769-772.
Crossref
Crossref
Shafiqur Rahman. 2011. The Brain as a Drug Target. The Brain as a Drug Target
349
365
.
Stephen I. Rennard. 2011. COPD. COPD
129
147
.
Svetlana Semenova & Athina Markou. (2010) The α2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats. European Neuropsychopharmacology 20:10, pages 731-746.
Crossref
Crossref
Taryn G. Moss, Andrea H. Weinberger, Jennifer C. Vessicchio, Vincenza Mancuso, Sandra J. Cushing, Michael Pett, Kate Kitchen, Peter Selby & Tony P. George. (2010) A Tobacco Reconceptualization in Psychiatry: Toward the Development of Tobacco‐Free Psychiatric Facilities. The American Journal on Addictions 19:4, pages 293-311.
Crossref
Crossref
Kasisomayajula Viswanath, Roy S. Herbst, Stephanie R. Land, Scott J. Leischow & Peter G. Shields. (2010) Tobacco and Cancer: An American Association for Cancer Research Policy Statement. Cancer Research 70:9, pages 3419-3430.
Crossref
Crossref
Riju Ray, Nandita Mitra, Don Baldwin, Mengye Guo, Freda Patterson, Daniel F Heitjan, Christopher Jepson, E Paul Wileyto, Jinxue Wei, Thomas Payne, Jennie Z Ma, Ming D Li & Caryn Lerman. (2010) Convergent Evidence that Choline Acetyltransferase Gene Variation is Associated with Prospective Smoking Cessation and Nicotine Dependence. Neuropsychopharmacology 35:6, pages 1374-1382.
Crossref
Crossref
A. E. Leader, C. Lerman & J. N. Cappella. (2010) Nicotine vaccines: Will smokers take a shot at quitting?. Nicotine & Tobacco Research 12:4, pages 390-397.
Crossref
Crossref
Freda Patterson, Robert A. Schnoll & Caryn Lerman. 2011. Addiction Medicine. Addiction Medicine
991
1016
.
Riju Ray, Robert Schnoll & Caryn Lerman. 2010. Handbook of Behavioral Medicine. Handbook of Behavioral Medicine
479
498
.
Gustavo L. Kortmann, Cristina J. Dobler, Lisiane Bizarro & Claiton H.D. Bau. (2009) Pharmacogenetics of smoking cessation therapy. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B:1, pages 17-28.
Crossref
Crossref
Robert A. Schnoll & Freda Patterson. (2009) Sex heterogeneity in pharmacogenetic smoking cessation clinical trials. Drug and Alcohol Dependence 104, pages S94-S99.
Crossref
Crossref
Kenneth A. Perkins. (2009) Acute responses to nicotine and smoking: Implications for prevention and treatment of smoking in lower SES women. Drug and Alcohol Dependence 104, pages S79-S86.
Crossref
Crossref
Linda P. Dwoskin, Andrew M. Smith, Thomas E. Wooters, Zhenfa Zhang, Peter A. Crooks & Michael T. Bardo. (2009) Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochemical Pharmacology 78:7, pages 732-743.
Crossref
Crossref
Kimberly S. Johnson & Michael S. Tankersley. (2009) Smoking cessation toolbox for allergists. Annals of Allergy, Asthma & Immunology 103:4, pages 271-279.
Crossref
Crossref
Brian Hitsman, Taryn G Moss, Ivan D Montoya & Tony P George. (2009) Treatment of Tobacco Dependence in Mental Health and Addictive Disorders. The Canadian Journal of Psychiatry 54:6, pages 368-378.
Crossref
Crossref
Lola Galeote, Fernando Berrendero, S. Andreea Bura, Andreas Zimmer & Rafael Maldonado. (2008) Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice. The International Journal of Neuropsychopharmacology 12:05, pages 615.
Crossref
Crossref
Sergio D Iñiguez, Brandon L Warren, Eric M Parise, Lyonna F Alcantara, Brittney Schuh, Melissa L Maffeo, Zarko Manojlovic & Carlos A Bolaños-Guzmán. (2008) Nicotine Exposure during Adolescence Induces a Depression-Like State in Adulthood. Neuropsychopharmacology 34:6, pages 1609-1624.
Crossref
Crossref
R Ray, M Rukstalis, C Jepson, AA Strasser, F Patterson, K Lynch & C Lerman. (2008) Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence. Journal of Psychopharmacology 23:2, pages 168-176.
Crossref
Crossref
Riju RayRobert A. SchnollCaryn Lerman. (2009) Nicotine Dependence: Biology, Behavior, and Treatment. Annual Review of Medicine 60:1, pages 247-260.
Crossref
Crossref
Rafael Laniado-Laborín. (2009) Smoking and Chronic Obstructive Pulmonary Disease (COPD). Parallel Epidemics of the 21st Century. International Journal of Environmental Research and Public Health 6:1, pages 209-224.
Crossref
Crossref
Grażyna Biała. (2009) Interactions between nicotine and morphine in animal paradigmsInterakcje miedzy nikotyną i morfiną w modelach zwierzęcych. Annales UMCS, Pharmacia 22:2, pages 75-79.
Crossref
Crossref
J. D. Raybuck & T. J. Gould. (2009) Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL / 6 mice - a role for high-affinity β2 subunit-containing nicotinic acetylcholine receptors. European Journal of Neuroscience 29:2, pages 377-387.
Crossref
Crossref
Irina Stepanov, Steven G. Carmella, Shaomei Han, Angela Pinto, Andrew A. Strasser, Caryn Lerman & Stephen S. Hecht. (2009) Evidence for endogenous formation of N′-nitrosonornicotine in some long-term nicotine patch users. Nicotine & Tobacco Research 11:1, pages 99-105.
Crossref
Crossref
Freda Patterson, Christopher Jepson, Andrew A. Strasser, James Loughead, Kenneth A. Perkins, Ruben C. Gur, Joseph M. Frey, Steven Siegel & Caryn Lerman. (2009) Varenicline Improves Mood and Cognition During Smoking Abstinence. Biological Psychiatry 65:2, pages 144-149.
Crossref
Crossref
D F Heitjan, D A Asch, Riju Ray, Margaret Rukstalis, Freda Patterson & C Lerman. (2008) Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment. The Pharmacogenomics Journal 8:6, pages 391-399.
Crossref
Crossref
Riju Ray, James Loughead, Ze Wang, John Detre, Edward Yang, Ruben Gur & Caryn Lerman. (2008) Neuroimaging, genetics and the treatment of nicotine addiction. Behavioural Brain Research 193:2, pages 159-169.
Crossref
Crossref
Thomas A. Nguyen & Robert M. Anthenelli. (2008) The neurobiology and treatment of tobacco dependence. Current Cardiovascular Risk Reports 2:6, pages 427-433.
Crossref
Crossref
David V. Conti, Won Lee, Dalin Li, Jinghua Liu, David Van Den Berg, Paul D. Thomas, Andrew W. Bergen, Gary E. Swan, Rachel F. Tyndale, Neal L. Benowitz & Caryn Lerman. (2008) Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Human Molecular Genetics 17:18, pages 2834-2848.
Crossref
Crossref
H. Furberg, P. Lichtenstein, N. L. Pedersen, C. M. Bulik, C. Lerman & P. F. Sullivan. (2007) Snus use and other correlates of smoking cessation in the Swedish Twin Registry. Psychological Medicine 38:9, pages 1299-1308.
Crossref
Crossref
Trevor M. Penning & Caryn Lerman. (2008) Genomics of Smoking Exposure and Cessation: Lessons for Cancer Prevention and Treatment. Cancer Prevention Research 1:2, pages 80-83.
Crossref
Crossref
J. T. Powell. (2008) Non-Operative or Medical Management of Abdominal Aortic Aneurysm. Scandinavian Journal of Surgery 97:2, pages 121-124.
Crossref
Crossref
Konstantin Ostroumov, Asya Shaikhutdinova & Andrey Skorinkin. (2007) Modeling study of mecamylamine block of muscle type acetylcholine receptors. European Biophysics Journal 37:4, pages 393-402.
Crossref
Crossref
Elise M Weerts, Yu Kyeong Kim, Gary S Wand, Robert F Dannals, Jae Sung Lee, J James Frost & Mary E McCaul. (2007) Differences in δ- and μ-Opioid Receptor Blockade Measured by Positron Emission Tomography in Naltrexone-Treated Recently Abstinent Alcohol-Dependent Subjects. Neuropsychopharmacology 33:3, pages 653-665.
Crossref
Crossref
Abel Lajtha. (2008) Interrelated mechanisms in reward and learning. Neurochemistry International 52:1-2, pages 73-79.
Crossref
Crossref
David H. Johnson, William J. Blot, David P. Carbone, Adriana Gonzalez, Dennis Hallahan, Pierre P. Massion, Joe Bill Putnam & Alan B. Sandler. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1307
1366
.
Caryn Lerman, Robert A. Schnoll & Freda Patterson. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
397
406
.
Caryn Lerman, Mark G. LeSage, Kenneth A. Perkins, Stephanie S. O'Malley, Steven J. Siegel, Neal L. Benowitz & William A. Corrigall. (2007) Translational research in medication development for nicotine dependence. Nature Reviews Drug Discovery 6:9, pages 746-762.
Crossref
Crossref
J. Golledge & J.T. Powell. (2007) Medical Management of Abdominal Aortic Aneurysm. European Journal of Vascular and Endovascular Surgery 34:3, pages 267-273.
Crossref
Crossref
Glen D. Morgan, Cathy L. Backinger & Scott J. Leischow. (2007) The Future of Tobacco-Control Research. Cancer Epidemiology, Biomarkers & Prevention 16:6, pages 1077-1080.
Crossref
Crossref
Ramón Bataller. (2006) Time to ban smoking in patients with chronic liver diseases. Hepatology 44:6, pages 1394-1396.
Crossref
Crossref